Business Description

Description
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.05
Equity-to-Asset -3.98
Debt-to-Equity -0.84
Debt-to-EBITDA -0.99
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -99.57
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 20.6
3-Year EPS without NRI Growth Rate 20.6
3-Year FCF Growth Rate 11.2

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 82.94
9-Day RSI 68.88
14-Day RSI 58.64
6-1 Month Momentum % -10.47
12-1 Month Momentum % -52.67

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.39
Quick Ratio 0.39
Cash Ratio 0.06
Days Sales Outstanding 197.3

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.9
Shareholder Yield % -9.31

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -6618.92
Net Margin % -7170.27
FCF Margin % -5751.85
ROA % -264.82
ROIC % -581.21
ROC (Joel Greenblatt) % -20568.97

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -8.27
EV-to-EBITDA -8.3
EV-to-Revenue 542.81
EV-to-FCF -8.42
Earnings Yield (Greenblatt) % -12.09
FCF Yield % -11.92

Financials

SRBCF's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:SRBCF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sirona Biochem Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.027
EPS (TTM) ($) -0.006
Beta -0.18
Volatility % 72.55
14-Day RSI 58.64
14-Day ATR ($) 0.001631
20-Day SMA ($) 0.04592
12-1 Month Momentum % -52.67
52-Week Range ($) 0.0416 - 0.1218
Shares Outstanding (Mil) 255.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sirona Biochem Corp Filings

Filing Date Document Date Form
No Filing Data

Sirona Biochem Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Sirona Biochem Corp Frequently Asked Questions

What is Sirona Biochem Corp(SRBCF)'s stock price today?
The current price of SRBCF is $0.05. The 52 week high of SRBCF is $0.12 and 52 week low is $0.04.
When is next earnings date of Sirona Biochem Corp(SRBCF)?
The next earnings date of Sirona Biochem Corp(SRBCF) is .
Does Sirona Biochem Corp(SRBCF) pay dividends? If so, how much?
Sirona Biochem Corp(SRBCF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1